Publications by authors named "Rocio Bautista-Sanchez"
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Rheumatol Immunol Res
September 2024
Systemic sclerosis (SSc) or scleroderma is an autoimmune disease characterized by immune dysregulation which leads to progressive fibrosis of the skin and internal organs. Interstitial lung disease (ILD) is present in approximately 65% of patients with SSc and it accounts for approximately 40% of all SSc deaths. Risk factors associated with the development of systemic sclerosis related interstitial lung disease (SSc-ILD) include male sex, African heritage, high modified Rodnan skin score (mRSS), presence of anti-Scl-70/Topoisomerase I antibodies, and nucleolar pattern on antinuclear antibody (ANA).
View Article and Find Full Text PDFHomozygous factor V Leiden (FVL) is a rare condition, occurring in 0.2% of the white population. This disease's rarity and aggressive pathophysiology can represent a challenge even to the most experienced clinicians.
View Article and Find Full Text PDFArticle Synopsis
- - The study compared the likelihood of acute coronary syndrome (ACS) in patients aged 18 to 40 versus those older than 40, while considering secondary health conditions like systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APLS) along with traditional cardiovascular risk factors.
- - Data from a large national database covering 2016 to 2018 was analyzed, revealing that among younger patients (18-40 years), both SLE and APLS significantly increased the chances of ACS hospitalization, while traditional risk factors were linked to ACS in both age groups.
- - In patients older than 40, traditional cardiovascular risk factors overshadowed SLE and APLS, meaning these conditions did